Chemokine Receptor 2 Is a Theranostic Biomarker for Abdominal Aortic Aneurysms

Abdominal aortic aneurysm (AAA) is a degenerative vascular disease with a high mortality upon rupture. There is no diagnosis to predict the rupture nor effective medical therapies to prevent rupture. Here we demonstrate that the C-C chemokine receptor type 2 (CCR2) is a theranostic biomarker for AAA. In rat AAA models, we determined the potential of a CCR2-targeted positron emission tomography radiotracer [<sup>64</sup>Cu]Cu-DOTA-ECL1i predicting AAA rupture. Using a CCR2 inhibitor, we observed the effective prevention of rupture in AAA rat models. In humans, CCR2 positron emission tomography showed intense radiotracer uptake along the AAA wall in patients while little signal was observed in healthy volunteers.

Authors

Institutions

Publication Details

Journal
JACC Basic to Translational Science
Published
2025-04-23
DOI
https://doi.org/10.1016/j.jacbts.2025.02.010
Citations
8
Primary Topic
Aortic aneurysm repair treatments
Type
article
Field-Weighted Citation Impact
12.15

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Chemokine Receptor 2 Is a Theranostic Biomarker for Abdominal Aortic Aneurysms

Robert J. Gropler, Kory J. Lavine, Xuefeng Gao, Sergio Sastriques-Dunlop et al.
8 citations
JACC Basic to Translational Science
Aortic aneurysm repair treatments
12.15
article

Chemokine Receptor 2 Is a Theranostic Biomarker for Abdominal Aortic Aneurysms

Robert J. Gropler, Kory J. Lavine, Xuefeng Gao, Sergio Sastriques-Dunlop, Joseph E. Ippolito, Hannah Luehmann, Andrea Bredemeyer, Sean J. English, Yeona Kang, Deborah Sultan, Chieh‐Yu Lin, Xiaohui Zhang, Batool Arif, Dakkota Thies, Richard A. Laforest, Santiago Elizondo-Benedetto, Kitty Harrison, Lisa Detering, Mohamed Zaghloul, Christophe Combadière, M.A. Zayed, Jie Zheng, Gyu Seong Heo, Yongjian Liu, Laura McDonald
article en
8 citations

Abstract

Abdominal aortic aneurysm (AAA) is a degenerative vascular disease with a high mortality upon rupture. There is no diagnosis to predict the rupture nor effective medical therapies to prevent rupture. Here we demonstrate that the C-C chemokine receptor type 2 (CCR2) is a theranostic biomarker for AAA. In rat AAA models, we determined the potential of a CCR2-targeted positron emission tomography radiotracer [<sup>64</sup>Cu]Cu-DOTA-ECL1i predicting AAA rupture. Using a CCR2 inhibitor, we observed the effective prevention of rupture in AAA rat models. In humans, CCR2 positron emission tomography showed intense radiotracer uptake along the AAA wall in patients while little signal was observed in healthy volunteers.

JACC Basic to Translational ScienceVol. 10(7)
Centre National de la Recherche Scientifique (FR), Howard University (US), Inserm (FR), Washington University in St. Louis (US), Sorbonne Université (FR), Centre d'Immunologie et des Maladies Infectieuses (FR)
Alvin J. Siteman Cancer Center, National Institutes of Health, Stephenson Cancer Center
Good health and well-being
Openalex Percentile: Top 1%
Aortic aneurysm repair treatments
12.15
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.